(Q33376013)

English

Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery? (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

heparin-induced thrombocytopenia

1 reference

based on heuristic

inferred from title

Axel Ekkernkamp

3

object named as

Axel Ekkernkamp

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Andreas Greinacher

4

object named as

Andreas Greinacher

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Norbert Lubenow

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter Hinz

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

26 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

187-190

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Informed consent on heparin-induced thrombocytopenia during thrombosis prophylaxis. A pilot study including 460 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00891.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2007.00891.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33376013&oldid=1628078844"